Successful treatment with secukinumab of three psoriatic patients undergoing dialysis
Author:
Affiliation:
1. Department of Dermatology School of Medicine Keio University Tokyo Japan
2. Department of Dermatology Hiratsuka City Hospital Hiratsuka Japan
3. Department of Dermatology Tokyo Women's Medical University Medical Center East Tokyo Japan
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15132
Reference5 articles.
1. Successful treatment with ustekinumab of psoriasis vulgaris in a patient undergoing hemodialysis
2. Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failure
3. Case of psoriatic erythroderma induced by the discontinuation of the chronic use of topical steroid after dialysis initiation and successfully treated with secukinumab
4. Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
5. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-05
2. Successful Treatment with Bimekizumab of a Psoriatic Patient Undergoing Hemodialysis: A Case Report and Review of the Literature;Journal of Clinical Medicine;2024-04-12
3. Nephrologisches Management und Medikamentendosierung bei Rheumapatienten mit Niereninsuffizienz – Teil 2;Rheuma Plus / Schweiz;2024-03-08
4. Secukinumab is effective in a patient on haemodialysis for end‐stage renal disease and severe hidradenitis suppurativa;Journal of the European Academy of Dermatology and Venereology;2024-02-20
5. Nephrologisches Management und Medikamentendosierung bei Rheumapatienten mit Niereninsuffizienz;rheuma plus;2023-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3